1. Home
  2. KMDA vs TLS Comparison

KMDA vs TLS Comparison

Compare KMDA & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • TLS
  • Stock Information
  • Founded
  • KMDA 1990
  • TLS 1969
  • Country
  • KMDA Israel
  • TLS United States
  • Employees
  • KMDA N/A
  • TLS N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • TLS EDP Services
  • Sector
  • KMDA Health Care
  • TLS Technology
  • Exchange
  • KMDA Nasdaq
  • TLS Nasdaq
  • Market Cap
  • KMDA 410.6M
  • TLS 403.5M
  • IPO Year
  • KMDA N/A
  • TLS 2020
  • Fundamental
  • Price
  • KMDA $6.95
  • TLS $6.79
  • Analyst Decision
  • KMDA Strong Buy
  • TLS Hold
  • Analyst Count
  • KMDA 2
  • TLS 4
  • Target Price
  • KMDA $13.00
  • TLS $4.83
  • AVG Volume (30 Days)
  • KMDA 50.0K
  • TLS 1.2M
  • Earning Date
  • KMDA 11-12-2025
  • TLS 11-11-2025
  • Dividend Yield
  • KMDA 2.90%
  • TLS N/A
  • EPS Growth
  • KMDA 27.97
  • TLS N/A
  • EPS
  • KMDA 0.32
  • TLS N/A
  • Revenue
  • KMDA $169,517,000.00
  • TLS $116,739,000.00
  • Revenue This Year
  • KMDA $14.49
  • TLS $47.80
  • Revenue Next Year
  • KMDA $10.12
  • TLS $26.19
  • P/E Ratio
  • KMDA $20.92
  • TLS N/A
  • Revenue Growth
  • KMDA 9.67
  • TLS N/A
  • 52 Week Low
  • KMDA $5.17
  • TLS $1.83
  • 52 Week High
  • KMDA $9.16
  • TLS $7.06
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 44.35
  • TLS 68.11
  • Support Level
  • KMDA $6.84
  • TLS $6.53
  • Resistance Level
  • KMDA $7.15
  • TLS $7.06
  • Average True Range (ATR)
  • KMDA 0.19
  • TLS 0.42
  • MACD
  • KMDA -0.00
  • TLS -0.08
  • Stochastic Oscillator
  • KMDA 23.02
  • TLS 76.29

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: